⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SPRY News
ARS Pharmaceuticals, Inc. Common Stock
Lost Money on ARS Pharmaceuticals, Inc. (SPRY)? Join Class Action Before October 5, 2026 - Contact Levi & Korsinsky
accessnewswire.com
SPRY
SPRY INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that ARS Pharmaceuticals Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
SPRY
Bronstein, Gewirtz & Grossman LLC Urges ARS Pharmaceuticals Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
SPRY
SPRY Shareholder Alert: October 5, 2026 Lead Plaintiff Deadline in ARS Pharmaceuticals Inc. Securities Class Action - Contact Levi & Korsinsky
globenewswire.com
SPRY
Recover Investment Losses: Class Action Initiated Against ARS Pharmaceuticals, Inc. (SPRY)
accessnewswire.com
SPRY
Kaplan Fox Encourages ARS Pharmaceuticals Inc. (SPRY) Investors with Losses to Contact the Firm Before October 5, 2026 Ready to Announce with Confidence?
newsfilecorp.com
SPRY
Important Notice to Long-Term Shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY); Roblox Corporation (NYSE: RBLX); Symbotic Inc. (NASDAQ: SYM); and The Simply Good Foods Company (NASDAQ: SMPL): Grabar Law Office is Investigating Claims on Your Behalf
globenewswire.com
SPRY
RBLX
SYM
SMPL
ARS Pharmaceuticals, Inc. (SPRY) Lawsuit - Investors Urged to Contact Levi & Korsinsky Before October 5, 2026
accessnewswire.com
SPRY
Pomerantz LLP Calls Attention to Class Action Involving ARS Pharmaceuticals, Inc. – SPRY
accessnewswire.com
SPRY
Levi & Korsinsky Notifies ARS Pharmaceuticals, Inc. (SPRY) Investors - Lead Plaintiff Deadline on October 5, 2026
accessnewswire.com
SPRY